Lotemax Sm Gel
Product Images NDC 24208-507

2 FDA label images from Bausch & Lomb Incorporated · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lotemax Sm (NDC 24208-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Dbad897a 1c53 4cf2 836d C99c0bdfc1ba 00)

Chemstructure (Dbad897a 1c53 4cf2 836d C99c0bdfc1ba 00)
Chemical structure of loteprednol etabonate displayed with its molecular formula C24H31ClO7 and molecular weight 466.96. The diagram includes detailed chemical bonds and functional groups as part of the steroid-based corticosteroid compound.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38%, 5 g gel tube for ophthalmic use. The label includes active ingredients, storage instructions, prescription-only status, and manufacturer information by Bausch & Lomb Incorporated, Tampa, FL. The label also includes barcodes and a visual pattern with blue and gray squares.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.